Alloy Therapeutics is a biotechnology company that develops novel antibody therapeutics using its proprietary drug discovery platform. The company's platform combines advanced computational algorithms with high-throughput screening technologies to identify and optimize therapeutic antibodies for a wide range of diseases. Alloy Therapeutics' customers include pharmaceutical and biotechnology companies, who use the company's platform to accelerate their drug discovery programs. The company was founded in 2017 and is headquartered in Cambridge, Massachusetts.